Is oral levothyroxine as effective as its intravenous form in myxoedema crisis with catecholamine-refractory shock?

J Paediatr Child Health. 2022 Apr;58(4):717-718. doi: 10.1111/jpc.15640. Epub 2021 Jun 30.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Catecholamines
  • Humans
  • Hypothyroidism* / drug therapy
  • Myxedema* / drug therapy
  • Shock*
  • Thyroxine / therapeutic use

Substances

  • Catecholamines
  • Thyroxine